PE20040527A1 - THE HYDROCHLORIDE OF (S) - (+) 3- [1- [2- (1-ACETYL-2,3-DIHYDRO-1H-INDOL-3-IL) ETHYL] -1,2,3,6-TETRAHYDROPYRIN- 4-IL] -6-CHLORINE-1H-INDOL - Google Patents

THE HYDROCHLORIDE OF (S) - (+) 3- [1- [2- (1-ACETYL-2,3-DIHYDRO-1H-INDOL-3-IL) ETHYL] -1,2,3,6-TETRAHYDROPYRIN- 4-IL] -6-CHLORINE-1H-INDOL

Info

Publication number
PE20040527A1
PE20040527A1 PE2003000516A PE2003000516A PE20040527A1 PE 20040527 A1 PE20040527 A1 PE 20040527A1 PE 2003000516 A PE2003000516 A PE 2003000516A PE 2003000516 A PE2003000516 A PE 2003000516A PE 20040527 A1 PE20040527 A1 PE 20040527A1
Authority
PE
Peru
Prior art keywords
indol
dihydro
acetyl
chlorine
ethyl
Prior art date
Application number
PE2003000516A
Other languages
Spanish (es)
Inventor
Benny Bang-Andersen
Ole Nielsen
De Diego Heidi Lopez
Gitte Ludvig
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of PE20040527A1 publication Critical patent/PE20040527A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE CLORHIDRATO DE (S)-(+)-3-[1-[2-1-ACETIL-2,3-DIHIDRO-1H-INDOL-3-IL)ETIL]-1,2,3,6-TETRAHIDROPIRIDIN-4-IL]-6-CLORO-1H-INDOL, LOS HIDRATOS Y/O SOLVATOS DEL MISMO. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y METODO DE PREPARACION CON LA ADICION DE UN VEHICULO O DILUYENTE FARMACEUTICAMENTE ACEPTABLE. DICHO COMPUESTO ES UTIL PARA EL TRATAMIENTO DE SIGNOS POSITIVOS Y NEGATIVOS DE LA ESQUIZOFRENIA, OTRAS PSICOSIS O LA DEPRESIONREFERS TO A HYDROCHLORIDE COMPOUND OF (S) - (+) - 3- [1- [2-1-ACETYL-2,3-DIHYDRO-1H-INDOL-3-IL) ETHYL] -1,2,3 , 6-TETRAHYDROPYRIDIN-4-IL] -6-CHLORINE-1H-INDOLE, THE HYDRATES AND / OR SOLVATES OF THE SAME. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION AND METHOD OF PREPARATION WITH THE ADDITION OF A PHARMACEUTICALLY ACCEPTABLE VEHICLE OR THINNER. SAID COMPOUND IS USEFUL FOR THE TREATMENT OF POSITIVE AND NEGATIVE SIGNS OF SCHIZOPHRENIA, OTHER PSYCHOSES OR DEPRESSION

PE2003000516A 2002-05-31 2003-05-28 THE HYDROCHLORIDE OF (S) - (+) 3- [1- [2- (1-ACETYL-2,3-DIHYDRO-1H-INDOL-3-IL) ETHYL] -1,2,3,6-TETRAHYDROPYRIN- 4-IL] -6-CHLORINE-1H-INDOL PE20040527A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200200843 2002-05-31

Publications (1)

Publication Number Publication Date
PE20040527A1 true PE20040527A1 (en) 2004-08-30

Family

ID=38812779

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000516A PE20040527A1 (en) 2002-05-31 2003-05-28 THE HYDROCHLORIDE OF (S) - (+) 3- [1- [2- (1-ACETYL-2,3-DIHYDRO-1H-INDOL-3-IL) ETHYL] -1,2,3,6-TETRAHYDROPYRIN- 4-IL] -6-CHLORINE-1H-INDOL

Country Status (4)

Country Link
AR (1) AR040122A1 (en)
PE (1) PE20040527A1 (en)
TW (1) TW200400959A (en)
UY (1) UY27828A1 (en)

Also Published As

Publication number Publication date
UY27828A1 (en) 2003-12-31
AR040122A1 (en) 2005-03-16
TW200400959A (en) 2004-01-16

Similar Documents

Publication Publication Date Title
PE20050874A1 (en) BENZHIMIDAZOLONE COMPOUNDS THAT HAVE AGONIST ACTIVITY OF THE 5-HT4 RECEPTOR
MXPA06001273A (en) Novel compounds.
PE20011371A1 (en) DERIVATIVES OF 3- (3-ISOPROPYL-5-METHYL-4H-1,2,4-TRIAZOL-4-IL) -EXO-8-AZABICYCLO [3.2.1] OCTANE AS ANTAGONISTS OF CCR5 CHEMOKIN RECEPTORS
SI1663206T1 (en) 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imidazole-2-thione as non-sedating alpha 2a agonist
PE20050020A1 (en) DERIVATIVES 4- (2-OXO-2,3-DIHYDRO-1-H-IMIDAZO [4,5-b] PYRIDIN-1-IL) -N- (2-OXO-AZEPAN-3-IL) PIPERIDINIL-1- CARBOXAMIDE SUBSTITUTED AS CGRP RECEPTOR ANTAGONISTS
CL2010000204A1 (en) Intermediate compounds derived from 4-amino-3-methoxybenzamide; intermediate compound n- {4- [4- (cyclopropylmethyl) piperazin-1-yl] cyclohexyl} acetamide; Intermediate compound 2-Chloro-7-ethyl-7,8-dihydro-5-methyl-8- (1-methyl) -6 (5h) -pteridinone, useful in the preparation of substituted dihydropteridinones (divisional sol. 2077-05) .
PE20051173A1 (en) AZABYCLIC COMPOUNDS (3.1.0) HEXANS AS MODULATORS OF DOPAMINE D3 RECEPTORS
NO20063380L (en) Triazole derivatives as vasopressin antagonists
PE20040071A1 (en) SUBSTITUTED INDAZOLES, COMPOSITIONS CONTAINING THEM, MANUFACTURING PROCEDURE AND USE
AR031556A1 (en) DERIVATIVES OF 3- (DIARILMETILEN) -8-AZABICICLO [3.2.1] OCTANO AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND
RS51311B (en) Cyclopropyl amines as modulators of the histamine h3 receptor
PE20001084A1 (en) PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON'S DISEASE, ADHD AND MICROADENOMAS
MXPA05013733A (en) 2-aminobenzothiazoles as cb1 receptor inverse agonists.
PE20090357A1 (en) HETEROCYCLIC COMPOUNDS WITH ACTIVITY ON MUSCARINE M3 RECEPTORS
PT88206A (en) PROCESS FOR THE PREPARATION OF DERIVATIVES OF 2 - {(4-PIPERIDINYL) -METHYL} -1,2,3,4-TETRAHYDRO-9H-PYRIDO (3,4-B) INDOL AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
DE60230127D1 (en) INHIBITORS OF INTEGRIN ALPHA-V-BETA-6
PE20090712A1 (en) MODULATORS OF THE GAMMA SECRETASE
PE20070355A1 (en) SELECTED CGRP ANTAGONISTS AND PROCEDURES FOR THEIR PREPARATION
PE20091431A1 (en) COMPOUNDS DERIVED FROM AZETIDINES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
DOP2000000106A (en) 2- (3,5-BIS-TRIFLUOROMETIL-PHENYL) -N-METIL-N- (6-MORFOLIN-4-IL-4-O-TOLIL-PIRIDIN-3-IL) -ISOBUTIRAMIDA
PE20091617A1 (en) TIAZOLIL-DIHIDRO-INDAZOLES
CL2008001158A1 (en) Compounds derived from (piperidin-4-yl) - ([1,3,4] thiadiazol-2-yl) -amine or (piperidin-4-yl) - (thiazol-2-yl) -amine, receptor antagonists dopamine d2; pharmaceutical compositions containing them; and its use in the prevention and treatment of CNS diseases such as schizophrenia.
ATE277893T1 (en) N-(2-PHENYL-4-AMINO-BUTYL)-1-NAPHTHAMIDE AS NEUROKININ-1 RECEPTOR ANTAGONISTS
PE20090320A1 (en) PIPERIDINE-AMIDE DERIVATIVES
AR052332A1 (en) DERIVATIVES OF BENZDIOXANPIPERAZINE WITH A COMBINED AFFINITY FOR DOPAMINE-D2 RECEPTORS AND SEROTONINE REABSORTION SITES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS MEDICINES FOR THE TREATMENT OF CNS DISEASES

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed